Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 8455744

[Greater decrease in lung function in COPD during continuous rather than during symptom-oriented bronchodilator medication].

R Geijer
View original source ↗Export metadata ↓

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

Bronchodilator AgentsForced Expiratory VolumeHumansLung Diseases, ObstructiveCommentLetter

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R Geijer. 1993-03-06. [Greater decrease in lung function in COPD during continuous rather than during symptom-oriented bronchodilator medication].. https://pubmed.ncbi.nlm.nih.gov/8455744/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1996

An international perspective on anticholinergic therapy.

Since the introduction of inhaled quaternary anticholinergic bronchodilators, their clinical usefulness has been explored in a variety of settings. They have emerged as the inhaled bronchodilators of first choice in the management of chronic obstructive pulmonary disease (COPD). In other countries, they have also found an adjunctive role in the management of asthma. This may be best seen in the treatment of acute asthma where the combination of anticholinergic and adrenergic bronchodilators appear more effective than single-agent inhalation therapy. This finding appears consistently in large studies, whether in adult or pediatric populations. Such combination nebulizer therapy would appear to be cost effective, but further study is required.

Bronchodilator Agents↗
PubMed1996

Scorpion venoms: taking the sting out of lung disease.

Scorpion venoms contain specific toxins which block large conductance calcium-activated potassium (BKCa) channels. Use of these toxins has shown that a significant proportion of the action of bronchodilators such as beta-agonists, theophylline, and nitric oxide occurs as a result of the opening of BKCa channels. Similarly, these toxins have shown that inhibitors of airway neurotransmission also operate via BKCa channels. Drugs that open BKCa channels may be alternative bronchodilators (possibly "airway selective" and with fewer side effects) as well as inhibitors of pathophysiological neurogenic influences in asthma, chronic coughing and sneezing, and chronic bronchitis.

Bronchodilator Agents↗